TW
PFE icon

TrinityPoint Wealth’s Pfizer PFE Stock Holding History

TrinityPoint Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$5.31M Buy
200,195
+8,651
+5% +$235K 0.75% 28
2024
Q3 		$5.54M Buy
191,544
+88,258
+85% +$2.57M 0.8% 27
2024
Q2 		$2.89M Sell
103,286
-35,437
-26% -$976K 0.45% 58
2024
Q1 		$3.85M Buy
138,723
+5,351
+4% +$148K 0.64% 36
2023
Q4 		$3.84M Sell
133,372
-24,038
-15% -$727K 0.7% 28
2023
Q3 		$5.22M Buy
157,410
+6,782
+5% +$240K 1.04% 19
2023
Q2 		$5.53M Buy
150,628
+64,669
+75% +$2.52M 1.08% 20
2023
Q1 		$3.51M Buy
85,959
+6,727
+8% +$291K 0.75% 31
2022
Q4 		$4.06M Buy
79,232
+14,967
+23% +$718K 0.92% 24
2022
Q3 		$2.81M Buy
64,265
+25
+0% +$1.22K 0.64% 35
2022
Q2 		$3.37M Sell
64,240
-1,140
-2% -$58.1K 0.74% 31
2022
Q1 		$3.38M Buy
65,380
+273
+0.4% +$14.2K 0.61% 43
2021
Q4 		$3.85M Sell
65,107
-1,278
-2% -$63.3K 0.68% 38
2021
Q3 		$2.85M Buy
66,385
+4,127
+7% +$183K 0.55% 52
2021
Q2 		$2.44M Buy
62,258
+1,589
+3% +$61.8K 0.5% 52
2021
Q1 		$2.2M Sell
60,669
-56,606
-48% -$2.01M 0.51% 51
2020
Q4 		$4.38M Buy
117,275
+5,536
+5% +$203K 1.05% 21
2020
Q3 		$3.89M Buy
111,739
+49,396
+79% +$1.73M 1.08% 19
2020
Q2 		$1.93M Sell
62,343
-35,535
-36% -$1.21M 0.61% 43
2020
Q1 		$3.03M Buy
97,878
+34,883
+55% +$1.19M 1.2% 20
2019
Q4 		$2.34M Sell
62,995
-2,046
-3% -$72.9K 0.79% 30
2019
Q3 		$2.35M Buy
65,041
+37,293
+134% +$1.36M 0.82% 30
2019
Q2 		$1.13M Sell
27,748
-862
-3% -$34.2K 0.54% 49
2019
Q1 		$1.15M Buy
28,610
+6,870
+32% +$275K 0.57% 53
2018
Q4 		$900K Buy
+21,740
New +$902K 0.55% 51

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TrinityPoint Wealth's PFE Position: Q4 2024 in Review

TrinityPoint Wealth increased its Pfizer (PFE) stake by 4.5% in Q4 2024, buying an estimated $235K and bringing the position to 200,195 shares worth $5.31M. The position accounts for 0.75% of the portfolio, ranked #28.

TrinityPoint Wealth first reported a position in PFE in Q4 2018 and has held it in 25 quarters since. The position peaked at $5.54M in Q3 2024. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • TrinityPoint Wealth held 200,195 shares of Pfizer worth $5.31M as of Q4 2024.
  • TrinityPoint Wealth bought 8,651 Pfizer shares in Q4 2024, an estimated $235K.
  • Pfizer made up 0.75% of TrinityPoint Wealth's portfolio in Q4 2024, its #28 holding.
  • TrinityPoint Wealth first reported a position in Pfizer in Q4 2018 and has held it in 25 quarters since.
  • TrinityPoint Wealth's Pfizer position peaked at $5.54M in Q3 2024.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on TrinityPoint Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.